Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Hoth Therapeutics, Inc. (HOTH) had Normalized Income after Taxes of $-8.19M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-8.19M |
|
-- |
|
-- |
|
$8.22M |
|
$-8.22M |
|
$0.03M |
|
$-8.19M |
|
$-8.19M |
|
$-8.19M |
|
$-8.19M |
|
$-8.19M |
|
|
Normalized Income after Taxes |
$-8.19M |
$-8.22M |
|
$-8.22M |
|
6.38M |
|
6.38M |
|
$-1.28 |
|
$-1.28 |
|
| Balance Sheet Financials | |
$7.64M |
|
-- |
|
$0.07M |
|
$7.71M |
|
$0.83M |
|
-- |
|
$0.00M |
|
$0.83M |
|
$6.88M |
|
$6.88M |
|
$6.88M |
|
8.04M |
|
| Cash Flow Statement Financials | |
$-6.98M |
|
-- |
|
$4.74M |
|
$9.29M |
|
$7.04M |
|
$-2.25M |
|
$0.80M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.20 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.98M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-119.04% |
|
-119.04% |
|
-106.17% |
|
-119.04% |
|
$0.86 |
|
$-1.09 |
|
$-1.09 |
|